Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19.

MLA

Tran, Florian, et al. “Increased Protease-Activated Receptor 1 Autoantibodies Are Associated with Severe COVID-19.” ERJ Open Research, vol. 8, no. 4, Dec. 2022. EBSCOhost, https://doi.org/10.1183/23120541.00379-2022.

APA

Tran, F., Harris, D. M. M., Scharmacher, A., Graßhoff, H., Sterner, K., Schinke, S., Käding, N., Humrich, J. Y., Cabral-Marques, O., Bernardes, J. P., Mishra, N., Bahmer, T., Franzenburg, J., Hoyer, B. F., Glück, A., Guggeis, M., Ossysek, A., Küller, A., Frank, D., … Schreiber, S. (2022). Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19. ERJ Open Research, 8(4). https://doi.org/10.1183/23120541.00379-2022

Chicago

Tran, Florian, Danielle M M Harris, Alena Scharmacher, Hanna Graßhoff, Kristina Sterner, Susanne Schinke, Nadja Käding, et al. 2022. “Increased Protease-Activated Receptor 1 Autoantibodies Are Associated with Severe COVID-19.” ERJ Open Research 8 (4). doi:10.1183/23120541.00379-2022.